BioArctic AB
Biotechnology · Healthcare
CFO
2 appearances
Latest appearance 2026-08-26
CFO
BioArctic AB
Equibles does not estimate personal net worth.
Anders Martin Lööf is recorded as CFO at BioArctic AB. Anders Martin Lööf has spoken on 2 earnings calls across 1 company, most recently for BioArctic AB on August 26, 2026. BioArctic AB is classified in the Biotechnology industry within the Healthcare sector.
“And if we then turn to the LeCambi numbers, we can see that the LeCambi growth continues. The global Q2 sales were 29.3 billion yen, or roughly $184 million, representing a healthy 12% increase from the first quarter, or 27% increase from the second quarter of 2025.”
“I will then start with the Lekambi numbers where we saw solid growth globally. In Q4, the sales were at 20.7 billion yen or $134 million. That was a 15% increase from the last quarter or 55% increase year over year.”
BioArctic AB
CFO
Transcript header (unverified)
BioArctic AB
Biotechnology · Healthcare
CFO
Interim Report Q2 2026
BioArctic AB
Full Year Report 2025
BioArctic AB